ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BBH VanEck Biotech ETF

158.78
-1.85 (-1.15%)
Last Updated: 20:37:03
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2012
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 152k
Operating Income 0
Pre Tax Income 0
Net Income 13k
Preferred Dividends 0
Basic Earnings Per Share (EPS) 0
EBIT 13k
EBITDA 13k
Year End 30 September 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 5.66M4.28M2.59M3.05M3.06M3.77M3.88M4.09M
Operating Income 00000000
Pre Tax Income 00000000
Net Income 3.14M2.16M-58.29M117.15M117.2M-181.28M45.87M61.84M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 0.5870.618-21.61239.08840.111-61.51315.83424.28
EBIT 3.14M2.16M1.22M1.63M1.2M2.06M2.15M2.51M
EBITDA 3.14M2.16M1.22M1.63M1.2M2.06M2.15M2.51M

Your Recent History

Delayed Upgrade Clock